UAE approves Leqembi, an Alzheimer's treatment, for mild cognitive impairment/mild dementia patients.

The UAE Ministry of Health approves Leqembi (lecanemab), an Alzheimer's treatment, for patients with mild cognitive impairment or mild dementia. Developed by BioArctic and Eisai, Leqembi is designed to reduce the rate of disease progression and slow cognitive and functional decline. This marks the first approval in the region for a treatment targeting Alzheimer's disease pathology.

August 14, 2024
6 Articles